Ads
related to: photodynamic therapy for diabetic retinopathy
Search results
Results From The WOW.Com Content Network
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders (particularly diseases of the retina). She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first
Recovery of visual acuity usually follows. Treatment should be considered if resorption does not occur within 3–4 months, [19] spontaneously or as the result of counselling. [1] The available evidence suggests that half-dose (or half-fluence) photodynamic therapy is the treatment of choice for CSR with subretinal fluid for longer than 3–4 ...
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.
Proliferative diabetic retinopathy PDT Photodynamic therapy: PK Penetrating keratoplasy: POAG Primary open-angle glaucoma PPDR Preproliferative diabetic retinopathy PRA Pan-retinal ablation PRK Photorefractive keratectomy PRP Pan-retinal photocoagulation PSCC Posterior sub-capsular cataract PVD Posterior vitreous detachment PXF
The American Academy of Ophthalmology practice guidelines recommend laser coagulation for people who have both mild to moderate nonproliferative diabetic retinopathy (NPDR) and clinically significant macular edema outside the fovea; treatment with anti-VEGF drugs is better than laser coagulation for clinically significant macular edema in the fovea. [1]
Treatment is based on the cause of the retinopathy and may include laser therapy to the retina. Laser photocoagulation therapy has been the standard treatment for many types of retinopathy. Evidence shows that laser therapy is generally safe and improves visual symptoms in sickle cell and diabetic retinopathy.